The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of SECN-15, a neuropilin-1–targeting antisense oligonucleotide, on resistance to immune checkpoint inhibitors in preclinical tumor models.
 
Richard Klar
Employment - Secarna Pharmaceuticals
Leadership - Secarna Pharmaceuticals
 
Anne Sadewasser
Employment - Secarna Pharmaceuticals
 
Julia Festag
Employment - Secarna Pharmaceuticals
 
Sven Michel
Employment - Secarna Pharmaceuticals
 
Monika Schell
Employment - Secarna Pharmaceuticals
 
Janani Sekar
Employment - Secarna Pharmaceuticals
 
Stefanie Raith
Employment - Secarna Pharmaceuticals
 
Konstantin Petropoulos
Employment - Secarna Pharmaceuticals
Leadership - Secarna Pharmaceuticals
 
Tiantom Jarutat
Employment - iOmx Therapeutics
Leadership - iOmx Therapeutics
Stock and Other Ownership Interests - iOmx Therapeutics
Consulting or Advisory Role - Secarna Pharmaceuticals
 
Frank Jaschinski
Employment - Secarna Pharmaceuticals
Leadership - Secarna Pharmaceuticals